Halaven
Halaven Products are primarily used for
Metastatic breast cancer
About Halaven Products
Uses of Halaven Products
Eribulin Mesylate is used in the treatment of metastatic breast cancer. It is used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other anticancer medicines after the cancer has spread.
Halaven Products side effects
Common
Side Effects of Halaven are Anemia (low number of red blood cells), Weakness, Hair loss, Nausea, Constipation, Decreased white blood cell count, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand).
How Halaven Products work
Eribulin Mesylate is an anticancer medication. It works by interfering with the microtubule structures which help the cancer cells to divide and multiply. This blocks the growth cycle (cell cycle) of cancer cells and eventually kills them.
Patient Concerns about Halaven Products
Frequently asked questions about Halaven Products
Frequently asked questions about Eribulin Mesylate
Q. Is hair loss caused by Halaven 1mg Injection irreversible?
Hair loss is a common side effect of Halaven 1mg Injection. It could be reversible but the severity of hair loss varies from person to person. Consult your doctor if you have any concerns regarding hair loss.
Q. How long can I stay on Halaven 1mg Injection?
Halaven 1mg Injection is usually given on Days 1 and 8 of each recommended 21-day cycle. The duration of treatment varies from person to person. The number of cycles required for effective treatment will be decided by your doctor. Depending on the results of your blood tests, the doctor may need to delay administration of the medicine until the blood tests return to normal. If required, the doctor may also decide to reduce the dose you are given.
Q. How is Halaven 1mg Injection Mesylate administered?
Halaven 1mg Injection will be given to you by a doctor or healthcare professional as an injection into a vein, over a period of 2 to 5 minutes. The dose required will be decided based on your body surface area (expressed in square metres, or m2) which is calculated from your weight and height. The doctor may adjust the usual dose based on your blood test results or other factors. To ensure that the whole dose of Halaven 1mg Injection is given, it is recommended that a saline solution is flushed into the vein after Halaven 1mg Injection is given.
Q. What are the serious side effects of Halaven 1mg Injection?
Halaven 1mg Injection can cause serious side effects which include low white blood cell count (neutropenia). This can lead to serious infections that could lead to death. It can also cause numbness, tingling, or pain in your hands or feet (peripheral neuropathy). Peripheral neuropathy is common with Halaven 1mg Injection and sometimes can be severe. It can cause harm to the baby when administered to a pregnant woman.
Q. When can I plan a pregnancy if I am using Halaven 1mg Injection?
Women of childbearing age should use effective contraception during and up to 3 months after treatment with Halaven 1mg Injection.It may cause serious birth defects and should not be used if you are pregnant unless it is thought clearly necessary after carefully considering all the risk to you and the baby.
Q. What precautions should be followed while handling Halaven 1mg Injection?
Halaven 1mg Injection should be handled carefully. Avoid any contact with skin, eyes, mouth and insides of nose. It is recommended to use gloves, goggles, and protective clothing while handling the medicine. If the skin comes into contact with the solution, it should be washed immediately and thoroughly with soap and water. Similarly, if your eyes, mouth or nose come in contact with Halaven 1mg Injection, flush the area thoroughly with water. Pregnant staff should not handle Halaven 1mg Injection.
Q. In which solution should Halaven 1mg Injection injection be diluted?
Halaven 1mg Injection may be diluted in up to 100 ml of sodium chloride 9 mg/ml (0.9%) solution and not in 5% dextrose. It should be given under the supervision of a physician experienced in giving cancer chemotherapy and should be administered by a health care professional only.